Related Experiment Video
Updated: Mar 21, 2026
Oxygen-Glucose Deprivation and Reoxygenation as an In Vitro Ischemia-Reperfusion Injury Model for Studying Blood-Brain Barrier Dysfunction
Published on: May 7, 2015
Caveolin-1 regulates the expression of tight junction proteins during hyperoxia-induced pulmonary epithelial barrier
Shuyan Xu1, Xindong Xue1, Kai You1
1Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, 110004, Liaoning, China.
Insights
Caveolin-1 (Cav-1) downregulation contributes to pulmonary epithelial barrier damage in bronchopulmonary dysplasia (BPD) by reducing tight junction proteins. Upregulating Cav-1 can protect against this hyperoxia-induced lung injury.
Area of Science:
- Pulmonary Medicine
- Cell Biology
- Neonatology
Background:
- Bronchopulmonary dysplasia (BPD) is a prevalent complication in preterm infants, characterized by impaired pulmonary epithelial barrier function due to reduced tight junction (TJ) proteins.
- The precise mechanisms driving TJ protein downregulation in early hyperoxia-induced BPD remain unclear.
- This study investigates the role of caveolin-1 (Cav-1) in the breakdown of the pulmonary epithelial barrier during BPD.
Purpose of the Study:
- To elucidate the role of caveolin-1 (Cav-1) in hyperoxia-induced pulmonary epithelial barrier disruption.
- To determine the impact of Cav-1 modulation on tight junction protein expression and barrier integrity.
Main Methods:
- Established in vitro pulmonary epithelial barrier models using primary rat alveolar epithelial cells (AEC-II).
- Exposed AEC-II to hyperoxia or normoxia, with interventions including Cav-1 siRNA for knockdown and Cav-1 cDNA transfection for upregulation.
- Assessed expression of Cav-1 and TJ proteins (ZO-1, occludin, claudin-4) via immunofluorescence, RT-PCR, and Western blotting; evaluated barrier function using transmission electron microscopy, transepithelial electrical resistance, and permeability assays.
Main Results:
- Hyperoxia exposure disrupted pulmonary epithelial barrier structure and function, decreasing expression of ZO-1, occludin, claudin-4, and Cav-1.
- Cav-1 knockdown under normoxia mimicked barrier disruption and reduced TJ protein expression.
- Cav-1 upregulation significantly protected against hyperoxia-induced barrier damage and TJ protein loss.
Conclusions:
- This study provides the first evidence linking Cav-1 downregulation to TJ protein loss and pulmonary epithelial barrier destruction in hyperoxia-induced BPD.
- Cav-1 plays a critical protective role in maintaining pulmonary epithelial barrier integrity under hyperoxic conditions.
- Targeting Cav-1 may offer a therapeutic strategy for preventing or treating BPD.
Background:
Bronchopulmonary dysplasia (BPD) is a common complication in preterm infants that involves the downregulation of tight junction (TJ) proteins. However, the mechanism underlying downregulation of the expression of TJ proteins during at the early stages of hyperoxia-induced BPD remains to be understood. Here, we aimed to identify the role of caveolin-1 (Cav-1) in hyperoxia-induced pulmonary epithelial barrier breakdown.
Methods:
First, we established an in vitro pulmonary epithelial barrier models using primary type II alveolar epithelial cells (AEC-II) from newborn rats. AEC-II was assigned to the hyperoxic (85 % O2/5 % CO2) or normoxic (21 % O2/5 % CO2) groups. Second, AEC-II was transfected with Cav-1-siRNA to downregulate Cav-1 under normoxic exposure. Third, AEC-II was transfected with a cDNA encoding Cav-1 to upregulate Cav-1 expression under hyperoxic exposure. Then, expression levels of Cav-1 and TJ proteins were examined by immunofluorescence staining, reverse transcription-polymerase chain reaction, and Western blotting. The TJ structures visualized using a transmission electron microscope, and transepithelial resistance and apparent permeability coefficient of fluorescein isothiocyanate-dextran, which are indicators of barrier function, were measured.
Results:
Our data showed that exposure to hyperoxia disrupted the structure and function of the pulmonary epithelial barrier and decreased the ZO-1, occludin, claudin-4, and Cav-1 expression levels. Moreover, Cav-1 knockdown attenuated the expression of the other three genes and disrupted pulmonary epithelial barrier structure and function under normoxic exposure. However, Cav-1 upregulation markedly antagonized the hyperoxia-induced pulmonary epithelial barrier destruction and TJ protein loss.
Conclusions:
This is the first study to present evidence illustrating the novel role of Cav-1 downregulation-mediated TJ protein loss in pulmonary epithelial barrier destruction during BPD.
Related Concept Videos
01:29Tight Junctions
01:24Regulation of Angiogenesis and Blood Supply
01:23Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:23Hypoxia
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
01:18Respiratory Regulation of Acid-Base Balance
When carbon dioxide levels increase in the blood, more H+ and HCO3⁻ are...